Senseonics/SENS

$0.63

-11.69%
-
1D1W1MYTD1YMAX

About Senseonics

Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. It is also developing its Gemini product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor that may be utilized with a smart transmitter to get continuous glucose readings and alerts or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose readings without a smart transmitter.

Ticker

SENS

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Timothy Goodnow

Employees

121

Headquarters

Germantown, United States

Senseonics Metrics

BasicAdvanced
$370.91M
Market cap
-
P/E ratio
-$0.06
EPS
0.90
Beta
-
Dividend rate

What the Analysts think about Senseonics

Analyst Ratings

Majority rating from 5 analysts.
Hold

Price Targets

Average projection from 3 analysts.
158.73% upside
High $2.50
Low $0.40
$0.63
Current price
$1.63
Average price target

Senseonics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-401.66% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$6M
46.34%
Net income
$-24.1M
18.14%
Profit margin
-401.66%
-19.27%

Senseonics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 29.13%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-
-$0.04
-$0.04
-$0.03
-
Expected
-$0.03
-$0.04
-$0.04
-$0.04
-$0.04
Surprise
-
3.23%
14.29%
-29.13%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Senseonics stock

Buy or sell Senseonics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing